Showing results (661-670 of 980) with videos related to

Sort By:
Pageof 98
Optics Letters|April 15, 2015
Sensing earth's rotation with a helium-neon ring laser operating at 1.15 μmK Ulrich Schreiber, Robert J Thirkettle, Robert B Hurst, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2011
Pulsed quantum optomechanicsM R Vanner, I Pikovski, G D Cole, et al.
Optics Express|November 29, 2012
THz quantum cascade lasers with wafer bonded active regionsM Brandstetter, C Deutsch, A Benz, et al.
Neuro-Oncology Practice|November 18, 2024
Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence databaseMichael P Castro, Jameson Quinn, Asher Wasserman, et al.
Journal of Veterinary Medical Education|November 6, 2024
A Multicenter Evaluation of a Metacognitive Framework for Antimicrobial Selection EducationStephen D Cole, Claire R Burbick, Joshua B Daniels, et al.
Chemphotochem|August 2, 2021
It Takes Three to Tango - the length of the oligothiophene determines the nature of the long-lived excited state and the resulting photocytotoxicity of a Ru(II) photodrugAvinash Chettri, John A Roque, Kilian R A Schneider, et al.
European Journal of Heart Failure|June 10, 2017
The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leafletsSameer Zaman, Saman S Zaman, Timothy Scholtes, et al.
Journal of Neuroscience Methods|December 13, 2016
Method for testing sustained attention in touchscreen operant chambers in ratsBrittany Wicks, David E Waxler, Kyle M White, et al.
Journal of Neuro-Oncology|January 30, 2008
Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor modelChad D Cole, James K Liu, Xiaoming Sheng, et al.
Pediatric Hematology and Oncology|September 25, 2010
Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group reportPeter D Cole, Kathleen M McCarten, Richard A Drachtman, et al.
Pageof 98